Standard BioTools Inc (NASDAQ: LAB) Not A Good Play Anymore?
Standard BioTools Inc (LAB) concluded trading on Thursday at a closing price of $1.05, with 5.81 million shares of worth about $6.1 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -52.91% during that period and on May 15, 2025 the price saw a […]
Standard BioTools Inc (LAB): A Great Stock For Handling Current Market Conditions?
Neuberger Berman Investment Advis recently announced the acquisition of new stake in Standard BioTools Inc (NASDAQ:LAB). The institutional investor has increased its shareholding in the Healthcare company by 0.86% to 4.54 million shares with purchase of 38558.0 shares. This fresh investment now brings its stake to 5.72% valued currently at $11.72 million. In addition, Morgan […]